Vapotherm (VAPO) Misses Q4 EPS by 13c, Revenues Beat; Offers 1Q Revenue Guidance Below Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Vapotherm Reports Fourth Quarter and Fiscal Year 2020 Financial Results
February 24, 2021 4:01 PM EST2020 Revenue of $125.7 Million Reflects 161.4% Increase Over Prior Year
Results in Line with Preliminary Revenue of $125.4 Million
Worldwide Installed Base of Precision Flow Hi-VNI® Systems Grew by 72.8% in 2020
EXETER, N.H.--(BUSINESS WIRE)-- Vapotherm, Inc. (NYSE: VAPO), (Vapotherm or the Company), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® products, which are used to treat Patients of all ages suffering from respiratory distress, today announced fourth quarter and fiscal year 2020... More
